The effect of adjuvant radiotherapy on oncological outcomes in patients with early-stage cervical carcinoma with only intermediate-risk factors: a propensity score matching analysis

References

• Barbera L, Thomas G. 2009. Management of early and locally advanced cervical cancer. Seminars in Oncology 36:155–169.
   PubMed Web of Science ®Google Scholar
• Berek JS, Adashi EY, Hillard PA. 2012. Cervical and vaginal cancer. In: Berek JS, editor. Berek&Novak’s gynecology. Philadelphia, PA: Lippincott Williams & Wilkins. p. 1207.
   Google Scholar
• Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. 2018. Cancer of the cervix uteri. International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics 143(Suppl 2):22–36.
   PubMed Web of Science ®Google Scholar
• Biewenga P, van der Velden J, Mol BWJ, Stalpers LJA, Schilthuis MS, van der Steeg JW, et al. 2009. Validation of existing prognostic models in patients with early-stage cervical cancer. Gynecologic Oncology 115:277–284.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 68:394–424.
   PubMed Web of Science ®Google Scholar
• Carcangiu M, Kurman RJ, Carcangiu ML, Herrington CS. 2014. WHO classification of tumours of female reproductive organs. France: International Agency for Research on Cancer.
   Google Scholar
• Chang C, Chen J, Chang WY, Chiang AJ. 2016. Tumor size has a time-varying effect on recurrence in cervical cancer. Journal of Lower Genital Tract Disease 20:317–320.
   PubMed Web of Science ®Google Scholar
• Chang SJ, Kim WY, Yoo SC, Yoon JH, Chun M, Chang KH, et al. 2009. A validation study of new risk grouping criteria for postoperative treatment in stage IB cervical cancers without high-risk factors: rethinking the Gynecologic Oncology Group criteria. European Journal of Obstetrics, Gynecology, and Reproductive Biology 147:91–96.
   PubMed Web of Science ®Google Scholar
• Chen TC, Huang HJ, Wang TY, Yang LY, Chen CH, Cheng YM, et al. 2015. Primary surgery versus primary radiation therapy for FIGO stages I–II small cell carcinoma of the uterine cervix: a retrospective Taiwanese Gynecologic Oncology Group study. Gynecologic Oncology 137:468–473.
   PubMed Web of Science ®Google Scholar
• Cibula D, Abu-Rustum NR, Fischerov D, Pather S, Lavigne K, Slama J, et al. 2018a. Surgical treatment of "intermediate risk" lymph node negative cervical cancer patients without adjuvant radiotherapy – a retrospective cohort study and review of the literature. Gynecologic Oncology 151:438–443.
   PubMed Web of Science ®Google Scholar
• Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C, et al. 2018b. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer. Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology 127:404–416.
   PubMed Web of Science ®Google Scholar
• Davila Fajardo R, van Os R, Buist MR, Uitterhoeve L, Westermann AM, Kenter GG, et al. 2014. Post-operative radiotherapy in patients with early stage cervical cancer. Gynecologic Oncology 134:52–59.
   PubMed Web of Science ®Google Scholar
• Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P, et al. 1997. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet (London, England) 350:535–540.
   PubMed Web of Science ®Google Scholar
• Pecorelli S. 2009. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics 105:103–104.
   PubMed Web of Science ®Google Scholar
• Peters WA, 3rd, Liu PY, Barrett RJ, 2nd, Stock RJ, Monk BJ, Berek JS, et al. 2000. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 18:1606–1613.
   PubMed Web of Science ®Google Scholar
• Rotman M, Sedlis A, Piedmonte MR, Bundy B, Lentz SS, Muderspach LI, et al. 2006. A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. International Journal of Radiation Oncology, Biology, Physics 65:169–176.
   PubMed Web of Science ®Google Scholar
• Rungruang B, Courtney-Brooks M, Beriwal S, Zorn KK, Richard SD, Olawaiye AB, et al. 2012. Surgery versus radiation therapy for stage IB2 cervical carcinoma: a population-based analysis. International Journal of Gynecologic Cancer 22:484–489.
   PubMed Web of Science ®Google Scholar
• Ryu SY, Park SI, Nam BH, Cho CK, Kim K, Kim BJ, et al. 2011. Is adjuvant chemoradiotherapy overtreatment in cervical cancer patients with intermediate risk factors? International Journal of Radiation Oncology Biology Physics 79:794–799.
   PubMed Web of Science ®Google Scholar
• Samlal RA, van der Velden J. 1999. Early cervical carcinoma: how to manage high-risk patients after radical hysterectomy. European Journal of Obstetrics, Gynecology, and Reproductive Biology 85:137–139.
   PubMed Web of Science ®Google Scholar
• Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ. 1999. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study. Gynecologic Oncology 73:177–183.
   PubMed Web of Science ®Google Scholar
• Sevin BU, Lu Y, Bloch DA, Nadji M, Koechli OR, Averette HE. 1996. Surgically defined prognostic parameters in patients with early cervical carcinoma. A multivariate survival tree analysis. Cancer 78:1438–1446.
   PubMed Web of Science ®Google Scholar
• Tuipae S, Yanaranop M, Oniem N. 2012. Role of adjuvant radiotherapy after radical hysterectomy in node-negative stage IB-IIA cervical cancer with intermediate risk factors. Journal of the Medical Association of Thailand = Chotmaihet Thangphaet 95(Suppl 3):S117–S124.
   PubMedGoogle Scholar
• Van der Velden J, Mom CH, van Lonkhuijzen L, Tjiong MY, Westerveld H, Fons G. 2019. Analysis of isolated loco-regional recurrence rate in intermediate risk early cervical cancer after a type C2 radical hysterectomy without adjuvant radiotherapy. International Journal of Gynecological Cancer 27:ijgc-2019-000445.
   Google Scholar
• Van der Velden J, Samlal R, Schilthuis MS, Gonzalez DG, ten Kate FJ, Lammes FB. 1999. A limited role for adjuvant radiotherapy after the Wertheim/Okabayashi radical hysterectomy for cervical cancer confined to the cervix. Gynecologic Oncology 75:233–237.
   PubMed Web of Science ®Google Scholar
• Zaino RJ, Ward S, Delgado G, Bundy B, Gore H, Fetter G, et al. 1992. Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study. Cancer 69:1750–1758.
   PubMed Web of Science ®Google Scholar